Investors & News

Progress, in the open.

Financial results, press releases, and updates on our clinical and platform milestones.

24VitalCare Announces Completion of Enrollment of 162 Patients Into the Phase 3 ASCEND Study

Read release

24VitalCare Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Read release

24VitalCare to Present at Upcoming Investor Conferences in June

Read release

24VitalCare Reports First Quarter 2026 Financial Results and Business Highlights

Read release